Objective: The authors used seven definitions of response in panic disorder
to compare patient-rated improvements in quality of life between patients
with panic disorder who responded to sertraline and those who responded to
placebo.
Method: They combined and examined data from two multicenter, randomized, d
ouble-blind, parallel-group, flexible dose studies of panic disorder (N=302
).
Results: Significant differences in quality of life between patients who re
sponded to sertraline and those who responded to placebo were apparent acro
ss all the definitions of clinical response.
Conclusions: Patients who respond to placebo in panic disorder treatment st
udies may show symptom relief but may not experience improvement in quality
of life. Determinations of quality of life should be included as component
s of both standard clinical assessment and clinical treatment studies of pa
tients with panic disorder.